- ►diabetesjournals.org JJ Wang, SX Zhang, K Lu, Y Chen, R Mott, S … - Diabetes, 2005 - Am Diabetes Assoc Pigment epithelium-derived factor (PEDF) is a potent angiogenic inhibitor.
Previous studies have shown that decreased ocular levels of PEDF are associated
with diabetic retinopathy. However, the implication of PEDF expression in ... Cited by 33 - Related articles - All 6 versions
JJ Wang, SX Zhang, R Mott, RR Knapp, W Cao … - Diabetes, 2006 - Am Diabetes Assoc Diabetic nephropathy is a major complication of diabetes and a leading cause of
end-stage renal diseases in the US Pigment epithelium–derived factor (PEDF) is
a potent angiogenic inhibitor that has been extensively studied in diabetic ... Cited by 20 - Related articles - BL Direct - All 5 versions
M Greener - Molecular Medicine Today, 2000 - Elsevier Diabetes poses an increasing public health problem across much of the developed
world. In particular, the increasing prevalence of type II diabetes reflects
lengthening life expectancies and larger numbers of obese people. However, ... Cited by 7 - Related articles - All 3 versions
- ►endojournals.org S Yamagishi, H Adachi, A Abe, T Yashiro, M … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: Pigment epithelium-derived factor (PEDF), a potent inhibitor of
angiogenesis with neuronal differentiating activity, inhibits endothelial cell
injury in vitro, thus suggesting the involvement of PEDF in ... Cited by 41 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] S Goldfarb, FN Ziyadeh - Transactions of the American Clinical and …, 2001 - pubmedcentral.nih.gov Page 1. TRANSACTIONS OF THE AMERICAN CLINICAL AND CLIMATOLOGICAL ASSOCIATION,
VOL. 112, 2001 TGF-jl: A CRUCIAL COMPONENT OF THE PATHOGENESIS ... Cited by 23 - Related articles - BL Direct - All 4 versions
F Lopez-Casillas - Revista de investigación clínica; organo del Hospital … - ncbi.nlm.nih.gov 1: Rev Invest Clin. 2000 Sep-Oct;52(5):487-90. [Transforming growth factor-beta
(TGF-beta), keystone in diabetic nephropathy]. [Article in Spanish] ... Cited by 5 - Related articles
- ►nih.gov H Liu, JG Ren, WL Cooper, CE Hawkins, MR … - Proceedings of the National Academy of Sciences of …, 2004 - National Acad Sciences Vascular permeability plays a key role in a wide array of life-threatening and
sight-threatening diseases. Vascular endothelial growth factor can increase
vascular permeability. Using a model system for nonproliferative diabetic ... Cited by 72 - Related articles - BL Direct - All 16 versions
- ►endojournals.org N Ogata, M Matsuoka, K Matsuyama, C Shima, … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Context: Pigment epithelium-derived factor (PEDF) is a strong inhibitor of
angiogenesis. Eyes with diabetic retinopathy have low levels of ocular PEDF;
however, the PEDF levels in the blood of diabetics have still not been ... Cited by 15 - Related articles - BL Direct - All 3 versions
LP Abramson, V Stellmach, JA Doll, M … - Journal of pediatric surgery, 2003 - Elsevier From the Division of Pediatric Surgery, Children's Memorial Hospital, and the
Department of Pathology, Northwestern University Medical School, Chicago, IL. ... Background/Purpose: Pigment epithelium[ndash ]derived factor (PEDF), a ... Cited by 49 - Related articles - BL Direct - All 12 versions
AJ Jenkins, SX Zhang, KG Rowley, CS … - Diabetic Medicine, 2007 - pt.wkhealth.com 1 A subset of these data was presented as an oral presentation at the 2006
Australian Diabetes Society Annual Meeting, and an abstract to the 2006 American
Diabetes Society Meeting was published in Diabetes, 2006; 55 (suppl. 1), A504. Cited by 9 - Related articles - BL Direct - All 5 versions
